Insider Transactions in Q1 2023 at Neuroone Medical Technologies Corp (NMTC)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.71%
|
$252
$1.61 P/Share
|
|
Mar 31
2023
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
90
-0.03%
|
$90
$1.61 P/Share
|
|
Mar 31
2023
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,239
-0.49%
|
$2,239
$1.61 P/Share
|
|
Mar 23
2023
|
Mark Christianson Business Development Director |
SELL
Open market or private sale
|
Direct |
12,711
-3.63%
|
$12,711
$1.5 P/Share
|
|
Mar 22
2023
|
Mark Christianson Business Development Director |
SELL
Open market or private sale
|
Direct |
11,667
-3.22%
|
$11,667
$1.51 P/Share
|
|
Mar 21
2023
|
Mark Christianson Business Development Director |
SELL
Open market or private sale
|
Direct |
2,122
-0.58%
|
$2,122
$1.6 P/Share
|
|
Mar 16
2023
|
Jeffrey S Mathiesen |
BUY
Grant, award, or other acquisition
|
Direct |
20,576
+19.19%
|
-
|
|
Mar 16
2023
|
Paul Buckman Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,576
+20.21%
|
-
|
|
Mar 16
2023
|
Edward Andrle Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,576
+24.26%
|
-
|
|
Feb 03
2023
|
Steve Mertens Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,054
-14.5%
|
$6,054
$1.47 P/Share
|
|
Feb 03
2023
|
Mark Christianson Business Development Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,175
-0.59%
|
$2,175
$1.47 P/Share
|
|
Feb 03
2023
|
David A Rosa CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
53,750
-10.44%
|
$53,750
$1.47 P/Share
|